| SC 13G | 2024-04-22 | BIO-RAD LABORATORIES, INC. | Oncocyte Corp | 1,200,109 | 9.0% | EDGAR |
| SC 13G/A | 2024-03-11 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 2,427,137 | 10.4% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 2,389,889 | 9.9% | EDGAR |
| SC 13G/A | 2024-01-29 | BlackRock Inc. | BIO-RAD LABORATORIES, INC. | 1,466,226 | 6.1% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | BIO-RAD LABORATORIES, INC. | 235,684 | 1.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 2,391,436 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | BIO-RAD LABORATORIES, INC. | 1,582,313 | 6.4% | EDGAR |
| SC 13D/A | 2022-04-11 | SCHWARTZ ALICE N | BIO-RAD LABORATORIES, INC. | 4,555,452 | 89.7% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | BIO-RAD LABORATORIES, INC. | 1,928,323 | 7.8% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 2,287,465 | 9.2% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | BIO-RAD LABORATORIES, INC. | 1,768,081 | 7.1% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 2,272,373 | 9.2% | EDGAR |
| SC 13G | 2021-02-08 | FMR LLC | BIO-RAD LABORATORIES, INC. | 1,692,254 | 6.8% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | BIO-RAD LABORATORIES, INC. | 1,892,336 | 7.6% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 1,977,527 | 8.0% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | BIO-RAD LABORATORIES, INC. | 2,319,052 | 9.3% | EDGAR |
| SC 13D/A | 2019-07-12 | SCHWARTZ ALICE N | BIO-RAD LABORATORIES, INC. | 4,555,974 | 89.3% | EDGAR |
| SC 13G/A | 2019-02-15 | EATON VANCE MANAGEMENT | BIO-RAD LABORATORIES, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | BIO-RAD LABORATORIES, INC. | 1,886,065 | 7.6% | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | BIO-RAD LABORATORIES, INC. | 1,936,008 | 7.8% | EDGAR |